Intraoperative NIR-II fluorescence guidance for precise tumor margin assessment and maximized tissue preservation in breast surgery
Open Access
- 30 June 2026
- journal article
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Abstract
Accurate margin assessment remains a challenge in breast-conserving surgery, where inaccuracy leads to excessive removal and compromised aesthetics. Although second near-infrared (NIR-II) fluorescence imaging offers high contrast, there is still a lack of clinically viable NIR-II equipment. We develop an innovative NIR-II fluorescence navigation platform based on indocyanine green (ICG) that enables rapid deployment, operation-friendly workflow, and precision-at-hand capability for intraoperative guidance. Thirty-seven patients were recruited with 1 mg/kg ICG injection 45 minutes before surgery. Image quality was evaluated using perception-based image quality evaluator (PIQE) score, while quantitative analyses of fluorescence, including tumor-to-normal tissue ratio (TNR) and signal-to-background ratio (SBR), together with histopathology and a multi-level reader study, were performed to assess tumor contrast and diagnostic performance. Compared to conventional NIR-I imaging, our NIR-II system demonstrates performance with enhanced spatial resolution and a higher tumor-to-normal tissue ratio (4.383 ± 1.719 versus 3.154 ± 1.072, P < 0.0001) in 37 patients. The intraoperative NIR-II imaging demonstrates superior tumor detection sensitivity [90.63% (75.78%-96.76%) vs. 84.38% (68.25%-93.14%)], with 100% diagnostic accuracy in delineating malignant tumor margins. Ex vivo NIR-II imaging enables real-time, precise visualization of tumor margins and suggested its potential to reduce the volume of excision. (NIR-II-defined volume < NIR-I-defined volume < current resection volume). Through brief training, surgeons can effectively utilize NIR-II imaging, shortening the learning curve for young surgeons in tumor and margin assessment. This study demonstrates a clinically adaptable NIR-II imaging platform that expands intraoperative visualization without changing surgical workflow or adding operational burden, supporting standardized margin assessment and improved tissue preservation in breast surgery.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7244427)
- Natural Science Foundation of Beijing Municipality (7242281)
- National Key Research and Development Program of China (2024YFC3405303)
This publication has 42 references indexed in Scilit:
- Application of deep learning techniques for breath-hold, high-precision T2-weighted magnetic resonance imaging of the abdomenAbdominal Radiology, 2024
- First‐in‐human orbital tumor surgery guided by near‐infrared II window fluorescence imaging: A feasibility studyInterdisciplinary Medicine, 2024
- Initial Experience of NIR-II Fluorescence Imaging-Guided Surgery in Foot and Ankle SurgeryEngineering, 2024
- Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologiesBreast Cancer Research and Treatment, 2024
- Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021JAMA Network Open, 2023
- Novel Self‐Assembled Multifunctional Nanoprobes for Second‐Near‐Infrared‐Fluorescence‐Image‐Guided Breast Cancer Surgery and Enhanced Radiotherapy EfficacyAdvanced Science, 2023
- Design and application of organic contrast agents for molecular imaging in the second near infrared (NIR-II) windowPhotoacoustics, 2022
- New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissueEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancerBreast Cancer Research and Treatment, 2021
- Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014